Skip to content
No results
  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • 2026-01-07

MGIC Investment Corporation (NYSE:MTG) Poised For Near-Term Pullback As Valuation Exceeds Fundamentals

Recent operational momentum juxtaposes with stretched valuation, suggesting limited upside and an elevated risk of mean reversion in the coming weeks.
  • 2026-01-07

Concentrix Corporation (NASDAQ:CNXC) Signals Near-Term Momentum Despite Margin Pressure

Concentrix shows improving momentum across short-term technical measures while fundamentals reflect recovering revenue and cash generation against elevated leverage. WMDST’s valuation tags the stock as under-valued.
  • 2026-01-07

Plexus Corp. (NASDAQ:PLXS) Posts Momentum Reversal And Shows Under-Valued Outlook

Plexus enters a recovery phase supported by positive free cash flow and above-estimate earnings, while WMDST values the stock as under-valued.
  • 2026-01-07

Advanced Energy Industries, Inc. (NASDAQ:AEIS) Accelerates Gains As Data-Center Demand Strengthens Near-Term Momentum

Product launches and corporate actions have positioned Advanced Energy for continued operational momentum, while technical indicators signal a short-term bullish bias tempered by elevated volatility and valuation pressures.
  • 2026-01-06

Morgan Stanley, NYSE:MS (NYSE:MS) Sets Up Near-Term Consolidation Despite Continued Earnings Strength

Morgan Stanley shows persistent operational strength after an outsized EPS beat, while technical momentum suggests the stock sits in a near-term topping posture that favors consolidation or mean reversion.
  • 2026-01-06

Bilibili Inc. (NASDAQ:BILI) Accelerates Margin Expansion While Near-Term Momentum Builds

User engagement gains and expanding margins point to continued operational momentum; WMDST values the stock as under-valued given the company’s cash position and improving profitability.
  • 2026-01-06

Genmab A/S (NASDAQ:GMAB) Prioritizes Late-Stage Assets, Tightening Near-Term Focus

Genmab shifts capital and clinical effort toward its highest-impact late-stage programs while trimming lower-priority development, creating a near-term operational concentration. Strong cash generation and margins anchor valuation even as technical momentum shows recent waning.
  • 2026-01-06

EMCOR Group, Inc. (NYSE:EME) Extends Operational Momentum Despite Over-Valued Status

Strong project wins and fresh capital-return measures reinforce execution and cash generation. Near-term technical momentum supports further price resilience while WMDST’s current valuation classifies the stock as over-valued.
  • 2026-01-06

Nuvalent, Inc (NASDAQ:NUVL) Strengthens Balance Sheet Ahead Of Near-Term Clinical Catalysts

Nuvalent enters the next phase with a larger cash position and multiple clinical data inflection points on the calendar, presenting a near-term focus on capital efficiency and clinical readouts.
  • 2026-01-05

Commvault Systems, Inc. (NASDAQ:CVLT) Signals Near-Term Downside Pressure Despite Long-Term Undervaluation

Commvault’s fundamentals reveal durable cash strength but elevated leverage and compressed margins, while technical indicators point to short-term bearish momentum with conflicting momentum signals that could shape the next several weeks.
Prev
1 … 22 23 24 25 26 27 28 … 77
Next

Marvell Technology, Inc. (NASDAQ:MRVL) Accelerates Momentum; Under-Valued With Near-Term Upside

2025-10-10

Hims & Hers Health, Inc. (NYSE:HIMS) Strengthens Momentum As Subscriber Growth Fuels Near-Term Upside

2025-10-09

Global-E Online Ltd. (NASDAQ:GLBE) Accelerates Shareholder Returns While Expanding Post-Purchase Capabilities

2025-10-09

North American Construction Group Ltd. (NYSE:NOA) Secures Record Contract, Boosting Near-Term Revenue Visibility

2025-10-09

Plexus Corp. (NASDAQ:PLXS) Strengthens Margins While Momentum Signals Reverse

2025-10-09

Haemonetics Corporation (NYSE:HAE) Technical Strength Points To Near-Term Price Rebound

2025-10-09

The Cooper Companies, Inc. (NYSE:COO) Momentum Shifts, Opening Near-Term Upside

2025-10-08

Bio-Techne Corporation (NASDAQ:TECH) Accelerates Momentum Suggesting Near-Term Price Appreciation

2025-10-08

Civeo Corporation (NYSE:CVEO) Expands Australian Footprint Amid Near-Term Cash Pressure

2025-10-08

Diodes Incorporated (NASDAQ:DIOD) Momentum Weakens While Fundamentals Signal Overvaluation

2025-10-08

Franklin Covey Co. (NYSE:FC) Sees Potential Near-Term Rebound Amid Bearish Momentum

2025-10-08

TG Therapeutics, Inc. (NASDAQ:TGTX) Strengthens Profitability; Near-Term Momentum Shows Caution

2025-10-08

Selective Insurance Group, Inc. (NASDAQ:SIGI) Poised For Near-Term Upside As Momentum Rebounds

2025-10-08

Exxon Mobil Corporation (NYSE:XOM) Poised To Sustain Cash Generation Amid Margin Pressure

2025-10-08

Kirby Corporation (NYSE:KEX) Signals Near-Term Pullback Amid Overvaluation

2025-10-08

Endava plc (NYSE:DAVA) Shrinks Margins But Partnerships Support Near-Term Operational Stability

2025-10-08
Prev
1 … 32 33 34 35 36 37 38 … 49
Next

Trending now

Corcept Therapeutics Incorporated (NASDAQ:CORT) Endures Regulatory Rebuff; Volatility Likely To Persist
Agios Pharmaceuticals, Inc (NASDAQ:AGIO) Braces For Near-Term Volatility As AQVESME Commercialization Accelerates
Sonic Automotive, Inc (NYSE:SAH) Set For Stabilization With Select Upside Potential
REX American Resources Corporation (NYSE:REX) Poised For Near-Term Upside As Expansion Nears Completion